1-8 of 8
Debra M Bensen-Kennedy, MD
Close
Sort by
Journal Articles

Minimal Residual Disease (MRD) As Exploratory Endpoint in a Phase 1 Study of the Anti-CD123 Mab CSL362 Given As Post-Remission Therapy in Adult Acute Myeloid Leukemia (AML)

B. Douglas Smith, MD, Andrew W. Roberts, MBBS, PhD, Gail J. Roboz, MD, Mark DeWitte, VMD, Anna Ferguson, BSN, RN, Linda Garrett, RN, Tania Curcio, Kaysey F. Orlowski, Sue Dasen, MS, Debra M. Bensen-Kennedy, MD, Roland B. Walter, MD PhD MS
Journal: Blood
Blood (2015) 126 (23): 3819.
https://doi.org/10.1182/blood.V126.23.3819.3819
Published: 2015
Journal Articles

Rviii-Singlechain Pharmacokinetics and Safety in Children Less Than 12 Years of Age

Claudia Djambas Khayat, MD BS, Oleksandra Stasyshyn, MD, Genadi Iosava, Prof., D.M., Ph. D., Jeannie B Ong, MD, Faraizah Abdul Karim, MD, Debra M. Bensen-Kennedy, MD, Katie St. Ledger, MS, Tharin Limsakun, PhD, Alex Veldman, MD, Ingrid Pabinger, MD
Journal: Blood
Blood (2015) 126 (23): 3524.
https://doi.org/10.1182/blood.V126.23.3524.3524
Published: 2015
Journal Articles

Rviii-Singlechain in Surgical Prophylaxis: Efficacy and Safety of Continuous and Bolus Infusion

Claudia Djambas Khayat, MD BS, Johnny N. Mahlangu, MD, Ross I Baker, MD, Cindy A. Leissinger, MD, Elena Santagostino, MD PhD, Debra M. Bensen-Kennedy, MD, Katie St. Ledger, MS, Alex Veldman, MD, Ingrid Pabinger, MD
Journal: Blood
Blood (2015) 126 (23): 3525.
https://doi.org/10.1182/blood.V126.23.3525.3525
Published: 2015
Journal Articles

Population Pharmacokinetic Modeling and Simulation of Recombinant Single-Chain Factor VIII (r VIII-SingleChain) in Patients with Hemophilia a

Ying Zhang, PhD, Tharin Limsakun, PhD, Debra M. Bensen-Kennedy, MD, Alex Veldman, MD, Zhenling Yao, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2814.
https://doi.org/10.1182/blood.V124.21.2814.2814
Published: 2014
Journal Articles

First-in Man, Phase 1 Study of CSL362 (Anti-IL3Rα / Anti-CD123 Monoclonal Antibody) in Patients with CD123+ Acute Myeloid Leukemia (AML) in CR at High Risk for Early Relapse

B. Douglas Smith, MD, Gail J. Roboz, MD, Roland B. Walter, MD PhD, Jessica K. Altman, MD, Anna Ferguson, BSN, RN, Tania J. Curcio, R.N, Kaysey F. Orlowski, Linda Garrett, RN, Samantha J Busfield, PhD, Megan Barnden, PhD, Brad Sedgmen, PhD, Souravi Ghosh, PhD, Sarah Hosback, PhD, Roslyn Davis, MSc, Allison Dyson, BSc, Sue Dasen, MS, Mark DeWitte, VMD, Debra M. Bensen-Kennedy, MD, Andrew W. Roberts, MBBS, PhD
Journal: Blood
Blood (2014) 124 (21): 120.
https://doi.org/10.1182/blood.V124.21.120.120
Published: 2014
Journal Articles

Open-Label Bendamustine for Pediatric Patients with Relapsed or Refractory Acute Leukemia: Safety and Efficacy Outcomes,

Christopher Fraser, MD, Patrick A. Brown, MD, Gail C. Megason, MD, Hyo Seop Ahn, MD, Bin Cho, MD, Ivan I. Kirov, MD, Lawrence S. Frankel, MD, Richard Aplenc, MD, MSCE, Debra M. Bensen-Kennedy, MD, Mihaela C. Munteanu, MS, Jennifer Weaver, Paul Harker-Murray, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3602.
https://doi.org/10.1182/blood.V118.21.3602.3602
Published: 2011
Journal Articles

An Open-Label Study of CEP-701 in Patients with JAK2 V617F-Positive Polycythemia Vera and Essential Thrombocytosis

Alison R Moliterno, MD, Gail J. Roboz, MD, Martin Carroll, Selina Luger, MD, Elizabeth Hexner, MD, Debra M. Bensen-Kennedy, MD
Journal: Blood
Blood (2008) 112 (11): 99.
https://doi.org/10.1182/blood.V112.11.99.99
Published: 2008
Journal Articles

Assessment of Targeted Systemic Exposure Based on Ex-Vivo Concentrations of Bendamustine and Chlorambucil and Related Clinical Outcomes

Mona Darwish, PhD, Peter Brown, DPhil, Debra M Bensen-Kennedy, MD, Lauren Young
Journal: Blood
Blood (2008) 112 (11): 4211.
https://doi.org/10.1182/blood.V112.11.4211.4211
Published: 2008